Natera Operating Income 2014-2025 | NTRA
Natera annual/quarterly operating income history and growth rate from 2014 to 2025. Operating income can be defined as income after operating expenses have been deducted and before interest payments and taxes have been deducted.
- Natera operating income for the quarter ending September 30, 2025 was $-0.098B, a 148.05% increase year-over-year.
- Natera operating income for the twelve months ending September 30, 2025 was $-0.352B, a 45.34% increase year-over-year.
- Natera annual operating income for 2024 was $-0.222B, a 50.19% decline from 2023.
- Natera annual operating income for 2023 was $-0.446B, a 17.52% decline from 2022.
- Natera annual operating income for 2022 was $-0.541B, a 15.56% increase from 2021.
|
Natera Annual Operating Income (Millions of US $) |
|
|---|---|
| 2024 | $-222 |
| 2023 | $-446 |
| 2022 | $-541 |
| 2021 | $-468 |
| 2020 | $-216 |
| 2019 | $-116 |
| 2018 | $-115 |
| 2017 | $-135 |
| 2016 | $-101 |
| 2015 | $-60 |
| 2014 | $1 |
| 2013 | $-25 |
|
Natera Quarterly Operating Income (Millions of US $) |
|
|---|---|
| 2025-09-30 | $-98 |
| 2025-06-30 | $-110 |
| 2025-03-31 | $-79 |
| 2024-12-31 | $-65 |
| 2024-09-30 | $-39 |
| 2024-06-30 | $-44 |
| 2024-03-31 | $-74 |
| 2023-12-31 | $-85 |
| 2023-09-30 | $-111 |
| 2023-06-30 | $-112 |
| 2023-03-31 | $-138 |
| 2022-12-31 | $-142 |
| 2022-09-30 | $-119 |
| 2022-06-30 | $-143 |
| 2022-03-31 | $-137 |
| 2021-12-31 | $-140 |
| 2021-09-30 | $-150 |
| 2021-06-30 | $-115 |
| 2021-03-31 | $-63 |
| 2020-12-31 | $-74 |
| 2020-09-30 | $-56 |
| 2020-06-30 | $-52 |
| 2020-03-31 | $-35 |
| 2019-12-31 | $-35 |
| 2019-09-30 | $-21 |
| 2019-06-30 | $-29 |
| 2019-03-31 | $-32 |
| 2018-12-31 | $-30 |
| 2018-09-30 | $-27 |
| 2018-06-30 | $-27 |
| 2018-03-31 | $-31 |
| 2017-12-31 | $-47 |
| 2017-09-30 | $-26 |
| 2017-06-30 | $-28 |
| 2017-03-31 | $-35 |
| 2016-12-31 | $-42 |
| 2016-09-30 | $-27 |
| 2016-06-30 | $-23 |
| 2016-03-31 | $-10 |
| 2015-12-31 | $-17 |
| 2015-09-30 | $-21 |
| 2015-06-30 | $-15 |
| 2015-03-31 | $-6 |
| 2014-12-31 | |
| 2014-09-30 | $5 |
| 2014-06-30 | $-1 |
| 2013-12-31 | |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Services | $31.987B | $1.697B |
| Natera, Inc. offers genetic testing and diagnostics with proprietary bioinformatics and molecular technology. Natera, Inc. is headquartered in San Carlos, California. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Danaher (DHR) | United States | $166.691B | 30.61 |
| HCA Healthcare (HCA) | United States | $107.089B | 17.73 |
| CVS Health (CVS) | United States | $99.777B | 11.47 |
| Elevance Health (ELV) | United States | $83.311B | 12.22 |
| Cencora (COR) | United States | $68.839B | 22.19 |
| DiDi Global (DIDIY) | China | $23.485B | 21.70 |
| Labcorp Holdings (LH) | United States | $22.455B | 17.12 |
| Medpace Holdings (MEDP) | United States | $17.208B | 42.72 |
| EUROFINS SCIENT (ERFSF) | Luxembourg | $16.445B | 0.00 |
| Viatris (VTRS) | United States | $14.812B | 5.52 |
| BioMerieux (BMXMF) | France | $14.802B | 0.00 |
| ICON (ICLR) | Ireland | $14.747B | 14.63 |
| Solventum (SOLV) | United States | $13.786B | 13.38 |
| Revvity (RVTY) | United States | $12.755B | 23.49 |
| CochLear (CHEOY) | Australia | $11.760B | 0.00 |
| Charles River Laboratories (CRL) | United States | $10.813B | 20.83 |
| Avantor (AVTR) | United States | $8.291B | 12.67 |
| Sonic Healthcare (SKHHY) | Australia | $7.752B | 0.00 |
| Caris Life Sciences,�Inc (CAI) | United States | $7.556B | 0.00 |
| HealthEquity (HQY) | United States | $7.294B | 27.27 |
| BrightSpring Health Services (BTSG) | United States | $7.070B | 42.15 |
| Bausch + Lomb (BLCO) | Canada | $6.078B | 39.91 |
| PACS (PACS) | United States | $6.072B | 36.92 |
| Sotera Health (SHC) | United States | $5.449B | 26.27 |
| Alignment Healthcare (ALHC) | United States | $4.502B | 0.00 |
| Amplifon S.p.A (AMFPF) | Italy | $3.719B | 21.70 |
| GeneDx Holdings (WGS) | United States | $3.124B | 54.86 |
| Concentras Parent (CON) | United States | $2.762B | 17.24 |
| Organon (OGN) | United States | $2.277B | 2.40 |
| Progyny (PGNY) | United States | $2.114B | 41.56 |
| Surgery Partners (SGRY) | United States | $2.057B | 26.50 |
| Establishment Labs Holdings (ESTA) | United States | $1.962B | 0.00 |
| Pediatrix Medical (MD) | United States | $1.877B | 11.21 |
| Ardent Health (ARDT) | United States | $1.231B | 4.02 |
| Teladoc Health (TDOC) | United States | $1.115B | 0.00 |
| Nutex Health (NUTX) | United States | $1.080B | 8.26 |
| CareDx (CDNA) | United States | $1.029B | 16.82 |
| Omada Health (OMDA) | United States | $0.933B | 0.00 |
| GoodRx Holdings (GDRX) | United States | $0.910B | 14.89 |
| InnovAge Holding (INNV) | United States | $0.794B | 0.00 |
| Embecta (EMBC) | United States | $0.734B | 4.17 |
| COMPASS Pathways (CMPS) | United Kingdom | $0.706B | 0.00 |
| Sonida Senior Living (SNDA) | United States | $0.594B | 0.00 |
| CryoPort (CYRX) | United States | $0.552B | 0.00 |
| Enhabit (EHAB) | United States | $0.532B | 23.91 |
| Strata Critical Medical (SRTA) | United States | $0.515B | 0.00 |
| Charming Medical (MCTA) | Hong Kong, SAR China | $0.497B | 0.00 |
| SBC Medicals (SBC) | United States | $0.445B | 8.19 |
| Agilon Health (AGL) | United States | $0.423B | 0.00 |
| Auna S.A (AUNA) | Luxembourg | $0.343B | 5.51 |
| Oncology Institute (TOI) | United States | $0.330B | 0.00 |
| Shoulder Innovations (SI) | United States | $0.288B | 0.00 |
| QDM (QDMI) | Hong Kong, SAR China | $0.279B | 58.75 |
| So-Young (SY) | China | $0.269B | 0.00 |
| KindlyMD (NAKA) | United States | $0.201B | 0.00 |
| Beauty Health (SKIN) | United States | $0.191B | 0.00 |
| LifeMD (LFMD) | United States | $0.181B | 0.00 |
| Sera Prognostics (SERA) | United States | $0.141B | 0.00 |
| Ascend Wellness Holdings (AAWH) | United States | $0.139B | 0.00 |
| DocGo (DCGO) | United States | $0.081B | 0.00 |
| Biodesix (BDSX) | United States | $0.063B | 0.00 |
| Park Dental Partners (PARK) | United States | $0.062B | 0.00 |
| IceCure Medical (ICCM) | Israel | $0.047B | 0.00 |
| NeuroOne Medical Technologies (NMTC) | United States | $0.046B | 0.00 |
| Pomdoctor - (POM) | China | $0.030B | 0.00 |
| Synergy CHC (SNYR) | United States | $0.020B | 6.21 |
| OSR Holdings (OSRH) | United States | $0.019B | 0.00 |
| Intelligent Bio Solutions (INBS) | United States | $0.018B | 0.00 |
| Basel Medical Group (BMGL) | Singapore | $0.016B | 0.00 |
| Lifeward (LFWD) | United States | $0.013B | 0.00 |
| SeaStar Medical Holding (ICU) | United States | $0.009B | 0.00 |
| BioNexus Gene Lab (BGLC) | $0.009B | 0.00 | |
| Pheton Holdings (PTHL) | China | $0.006B | 0.00 |
| ISpecimen (ISPC) | United States | $0.004B | 0.00 |
| Aclarion (ACON) | United States | $0.003B | 0.00 |
| XWELL (XWEL) | United States | $0.002B | 0.00 |
| INVO Fertility (IVF) | United States | $0.002B | 0.00 |
| NewGenIvf Group (NIVF) | Thailand | $0.000B | 0.00 |
| Cano Health (CANOQ) | United States | $0.000B | 0.00 |